Haystack Oncology
Who we are
Powered by pioneers in liquid biopsy
Haystack Oncology is based on over 20 years of liquid biopsy technology and clinical development led by the scientists specialized in cancer genomics who first envisioned non-invasive cancer screening, MRD detection, and advanced disease therapy monitoring. Their discoveries have positively affected millions of lives, and companies that employ their technology have generated billions of dollars in enterprise value.
Scientific Founders

Bert Vogelstein, M.D.
Professor of Oncology

Kenneth Kinzler, Ph.D.
Director, Ludwig Center at Johns Hopkins University Professor of Oncology

Nick Papadopoulos, Ph.D.
Professor of Oncology
Leadership
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Board of Directors
Executive Chairman
Isaac
Ro
Founder & Director
Dr. Nicholas
Papadopoulos
Director
Dan
Edelstein
Director
George C.
Petrocheilos
Director
R. Jacob
Vogelstein
Clinical Scientific Advisors
Haystack Oncology’s clinical advisory board brings a diversity of thought leadership among oncology experts, and is foundational to our mission of providing better MRD testing for better patient outcomes.
Chetan Bettegowda, MD, Ph.D.
Professor of Neurosurgery and Oncology | Vice Chair, Department of Neurosurgery
Johns Hopkins School of Medicine
Al Benson, MD
Professor of Medicine, Hematology and Oncology | NCCN Board of Directors | Chair, NCCN Hepatobiliary, Colon & Rectal Guidelines Panel | Member, NCCN Pancreatic Cancer and Neuroendocrine Panels
Northwestern University
Nilofer Saba Azad, MD
Professor of Oncology | Co-Director, Developmental Therapeutics Program/Phase I Program | NCCN Guidelines Panel, Colon Cancer
Nishant Agrawal, MD
Professor of Surgery | Chief of Otolaryngology-Head and Neck Surgery | Co-Director of Head and Neck Surgical Oncology
University of Chicago
Afsaneh Barzi, MD, Ph.D.
Associate Professor, Department of Medical Oncology & Therapeutics Research | Vice President, Quality and Value
City of Hope/AcessHope
Peter Gibbs, MD
Professor of Medicine
Walter and Eliza Hall Institute
Jeanne Tie, MD
Associate Professor of Medicine
Walter and Eliza Hall Institute
Patrick Boland, MD
Assistant Professor, Medical Oncology
Rutgers Cancer Institute
Andrea Cercek, MD
Associate Attending Physician | Section Head, Colorectal Cancer | Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Memorial Sloan Kettering Cancer Center
Richard Goldberg , MD
Emeritus Professor and Cancer Institute Director, West Virginia University | Associate Group Chair Alliance for Clinical Trials in Oncology
Cristian Tomasetti, PhD
Director, Center for Cancer Prevention and Early Detection, City of Hope
News & Events
The Latest
Find out what's happening at Haystack Oncology and stay up-to-date with industry news.
2023 ASCO Annual Meeting
We are excited to announce that Haystack Oncology will be participating in the American Society for Clinical Oncology (ASCO) annual meeting in Chicago, Il ...
Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
SOURCE Quest Diagnostics Goal to improve patient outcomes through early, accurate detection of residual or recurring cancer Haystack's highly sensit ...